FIBROGEN INC Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2014 to Q4 2021

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Fibrogen Inc annual/quarterly Share-based Payment Arrangement, Expense history and growth rate from Q1 2014 to Q4 2021.
  • Fibrogen Inc Share-based Payment Arrangement, Expense for the quarter ending December 31, 2021 was $17.1M, a 15.8% decline year-over-year.
  • Fibrogen Inc Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2021 was $71.2M, a 2.14% decline year-over-year.
  • Fibrogen Inc annual Share-based Payment Arrangement, Expense for 2023 was $50.8M, a 22.6% decline from 2022.
  • Fibrogen Inc annual Share-based Payment Arrangement, Expense for 2022 was $65.6M, a 7.81% decline from 2021.
  • Fibrogen Inc annual Share-based Payment Arrangement, Expense for 2021 was $71.2M, a 2.14% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2021 $71.2M $17.1M -$3.2M -15.8% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 $74.4M $15.7M -$2.19M -12.2% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $76.5M $19M +$1.36M +7.69% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $75.2M $19.4M +$2.47M +14.6% Jan 1, 2021 Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $72.7M $20.3M +$2.87M +16.5% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 $69.9M $17.9M +$3.1M +20.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $66.8M $17.6M +$2K +0.01% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $66.8M $16.9M +$486K +2.96% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $66.3M $17.4M +$3.69M +26.9% Oct 1, 2019 Dec 31, 2019 10-K/A 2022-03-04
Q3 2019 $62.6M $14.8M +$470K +3.28% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $62.1M $17.6M +$4.41M +33.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $57.7M $16.4M +$5.55M +51% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $52.1M $13.7M +$3.78M +38.1% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 $48.4M $14.3M +$4.7M +48.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $43.7M $13.2M +$3.66M +38.2% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $40M $10.9M +$2.47M +29.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $37.5M $9.93M +$2.06M +26.1% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-02
Q3 2017 $35.5M $9.63M +$1.12M +13.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $34.4M $9.57M +$1.17M +13.9% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $33.2M $8.41M +$1.07M +14.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $32.1M $7.88M +$427K +5.73% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 $31.7M $8.51M +$1.67M +24.4% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $30M $8.4M +$1.46M +21.1% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $28.6M $7.34M +$894K +13.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 $27.7M $7.45M -$1.52M -16.9% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-27
Q3 2015 $29.2M $6.84M -$1.43M -17.2% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 $30.6M $6.94M +$6.27M +936% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 $24.3M $6.45M +$5.65M +711% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $18.7M $8.96M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-01
Q3 2014 $8.27M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 $670K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 $795K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.